Title: William R. Brody
1 University Perspectives on InnovationSeptember
28, 2005BMES-IDEA meeting
- William R. Brody
- President, The Johns Hopkins University
2Subtitle Bill Brodys Recipe for Successful
Entrepreneurship Top 10 Dos and Donts
3Disclaimer
- Caution
- The views expressed in this presentation
represent those of William R. Brody and should
not be construed to represent the official
position of The Johns Hopkins University, which,
in any event, doesnt have an official position,
because no one can really speak for the entire
university
4Achtung!
- The material presented herein, other than that
stolen (or borrowed) by the author is the subject
of a pending patent application by the author.
Any use, reproduction, quotation, or other use of
this material without first obtaining a license
(or material transfer agreement) from William R.
Brody and The Johns Hopkins University Office of
Technology Licensing is expressly verboten. Such
license negotiations shall not take longer than
36 months to complete.
5Technology Transfer Started in 1884
- 1876 Johns Hopkins University Founded
- In 1879 Johns Hopkins chemistry professor Ira
Remsen discovers saccharin. - In 1884 assistant Constantin Fahlberg patents it.
6Early Approach to Patenting
- While at U. Chicago in 1942, Russell Morgan
invents the x-ray phototimer - The University sells the patent for 1 to GE
- Morgan moves to Johns Hopkins
- U of C solicits Mrs. Morgan for donation
7The Mertonian Tradition --Open Science
- In 1970 Nobelists Dan Nathans and Hamilton Smith
publish discovery of restriction enzymes - It never even occurred to us to seek a patent
8The Bayh-Dole Act of 1980
- Intended to promote the commercialization of
government-sponsored research - Prompted by low rate of licensing patents from
government research (many of which were
defense-related) - Intent was not to create a new revenue stream for
universities (though that effect was seen as a
possible benefit)
9Technology Transfer Revenue Growth
U.S. Universities Gross Licensing Revenue
FY1991 to FY2000
Source AUTM Licensing Survey FY2000
10Universities Vary Widely in Generating Licensing
Income
Institution Licenses Active Income in FY2000 Av. Income per License
Columbia 143 138,562,000 969,000
U. Penn 45 26,493,000 589,000
U. Ca. System 781 261,522,000 335,000
Emory 46 10,672,000 232,000
Johns Hopkins 166 14,376,000 87,000
Baylor 115 9,415,000 82,000
U. Washington 385 30,213,000 78,000
Harvard 163 12,195,000 75,000
U. Pittsburgh 47 3,259,000 69,000
Washington U. 255 8,396,000 33,000
Source AUTM Licensing Survey FY2000
11Why is this?
- Success in patent licensing requires one big
hit -- akin to winning the jackpot at Las Vegas - One big hit makes the licensing portolio
profitable this drives tech transfer offices to
focus on the potential home run - Must identify the one potential big hit from a
sea of possible invention disclosures
12Picking Winners -- how good are we?
- John Simpson
- Julio Palmaz
- Paul Bottomley
13Cardiac Surgery as a model for innovationDevelopm
ent of Valve Replacement Surgery
- Dr. Charles P. Bailey First successful mitral
valve commissurotomy, June 10, 1949 -?no company - Dr. C. Walton Lillehei VSD closure using
cross-circulation (1954) -?Medtronic - Dr. Richard DeWall Heart Lung Machine using
Bubble Oxygenator (1955) -?Bentley Labs - Dr. Albert Starr First successful mitral valve
replacement with Starr-Edwards ball-valve
prosthesis, August 25, 1960. -?Edwards
Laboratories
14Cardiac Surgery as a model for innovation Many
Companies Spawned
- Edwards Laboratories Shiley Laboratories
- Bentley Laboratories Pacesetter (Siemens)
- Medtronic Hancock Labs
- Advanced Cardiovascular Systems (Guidant)
- Boston Scientific Cordis (JJ)
- St. Jude Medical Ventritex
15So you want to start a company?
- Idea
- Intellectual property
- Investment Capital
- Management Team
- Define your personal objectives
- Make money?
- Get your idea into clinical practice
- Win a Nobel Prize
- Stay at the university get tenure
- Move into the commercial sector
16How to Avoid Making Mistakes
17Recipe for SuccessMedical StartupsTop 10 List
- 510 K rather than PMA
- Recurring revenue stream
- Significant barrier to entry
- Low development cost
- Cost effective/less invasive/safer/better must
be clearly evident
18Recipe for SuccessMedical StartupsTop 10 List
- New or rapidly emerging market with no dominant
competitor - Avoid Inventors Paranoia
- Dont serve two masters (conflict of commitment)
- Minimize Conflict of Interest
- Be Lucky
19Louis Pasteur
- Chance favors the prepared mind.
20Advice to the entrepreneur
- When you have become successful, give generously
back to your university - (and if you didnt go to a university in the
United States, please donate to Johns Hopkins
University)
21The End
22References
- On the Take, Jerome P. Kassirer, M.D. (2005,
Oxford University Press) - Universities in the Marketplace, Derek Bok (2003,
Princeton University Press) - Los Angeles Times articles on conflict of
interest among NIH senior scientists by David
Willman, December 7, 2003 and December 22, 2004
23COI Dilemma (as stated by Kassirer)
- Where does the line exist between advancing the
cause of science and the betterment of patient
care on the one hand, and the pecuniary interests
of the physicians collaborating with industry to
produce these advances on the other?
24I cannot be bought
- Thre is little doubt that substantial sums of
money induce physicians to drift across the line,
and as they do, financial conflicts of interest
can cause great damage. J.P. Kassirer
25Effects of Funding Source on Study Outcome
- Study on thromboembolic complications of 3rd
generation contraceptive agents by Richard Smith
in British Medical Journal - Funded by public money (e.g., NIH) showed
thromboembolic complications occurred with 3rd
generation contraceptive agents - Funded by pharma No complications recorded
26Blank
27Blank
28Blank
29Blank